CPBI earnings analysis
What we found in CPBI's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The provided 10-Q excerpt does not include the income statement, balance sheet, cash-flow statement, segment data, or MD&A financial results, so revenue, margins, EPS, liquidity, and year-over-year trends cannot be assessed from the filing text supplied. The company repurchased 16,348 shares during the quarter and had 112,330 shares remaining under its authorization as of June 30, 2026. Controls were reported effective, no material legal proceedings were identified, and no quantitative guidance was provided.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- 16,348 shares repurchased
- The company repurchased 16,348 shares during the quarter under its board-approved program, including 7,547 shares in June at an average price of $18.62 per share.
- 112,330 shares remain authorized
- The repurchase authorization had 112,330 shares remaining as of June 30, 2026, versus the original authorization of up to 200,000 shares.
- Effective disclosure controls
- Management concluded that disclosure controls and procedures were effective as of June 30, 2026, and reported no material change in internal control over financial reporting during the quarter.
- No material legal proceedings
- The company reported no pending legal proceedings other than routine ordinary-course matters, with no material expected impact on financial condition or results of operations.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Ongoing capital deployment
- The company repurchased 16,348 shares during the quarter, using cash that could otherwise support lending, investments, or other corporate purposes; 112,330 shares remained available under the program at June 30, 2026.
- Potential CFO severance obligation
- The CFO change-in-control agreement is included as Exhibit 10.1. The prior disclosed agreement provides severance of 3 times specified salary and bonus amounts and up to 18 months of COBRA reimbursement upon a qualifying termination.
- No updated risk-factor disclosure
- The filing states that risk-factor disclosure is not required because the company is a smaller reporting company; consequently, the provided 10-Q does not update risks relative to the prior filing.
What they said about what is next.
The provided 10-Q excerpt contains no quantitative revenue or EPS outlook. Numeric financial guidance was not provided.
The filing reads about the same as the one before it.
What came before.
- 10-K · June 18, 2026
- Central Plains Bancshares delivered solid fiscal 2026 growth, with assets up 9.8%, loans up 11.5%, net interest income up 12.8% and diluted EPS rising to $1.05. The strategy is emphasizing loan and deposit expansion,…
- 10-Q · February 11, 2026
- The provided extract does not include the income statement, balance sheet, cash-flow statement, segment disclosures, or MD&A, so operating trends and liquidity cannot be assessed. The company repurchased 12,083 shares…
- 10-Q · November 13, 2025
- The provided excerpt does not include the financial statements or MD&A, so revenue, margins, EPS, balance-sheet trends, cash flow, segment performance, and quantitative outlook cannot be assessed. The available…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing CPBI makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever